Health Policy | Telehealth What are the new requirements on prescribing controlled substances through telehealth? Due to COVID-19, a nationwide public health emergency was declared on Jan. 31. As such, The Drug Enforcement Administration (DEA) has relaxed rules previously in place with regards to prescribing controlled substances via telehealth. Per the DEA: “For as long as the Secretary’s designation of a public health emergency remains in effect, DEA-registered practitioners may issue prescriptions for controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional practice. The telemedicine communication is conducted using an audio-visual, real-time, two-way interactive communication system. The practitioner is acting in accordance with applicable Federal and State law.” The entire report can be read here. News & Knowledge All Curi recommendations are based on current CDC criteria at the time of publication. CDC guidance for SARS-CoV-2 infection may, or may not, be adopted by state and local health departments to respond to rapidly changing local circumstances. Providers should always check with their local health department to see if the CDC’s guidance on any given topic has been modified (particularly if more restrictive) from the CDC’s recommended guidelines. Follow this link https://www.cdc.gov/publichealthgateway/healthdirectories/index.html for contact information to your state/local health department. If local recommendations vary from those of the CDC, and you are unsure what recommendations to follow, then it is safer to follow the more restrictive guidelines/recommendations.